Method for preparation of orally administrated insulin formulation
View Patent ↗The invention relates to the method for preparation of orally administrated insulin oil formulation comprising: dissolving an amount of insulin in an acidic aqueous buffer(A); adding A to liquid surfactant, the HLB value of which is between 10 and 20, with agitation to form a homogeneous solution(B); adding B to an oil, the HLB value of which is between 0 and 10, with agitation to form oil formulation. This invention has a simple process with low cost. After orally administrated, the formulation prepared with the process of the invention can resist the gastrointestinal degradation by digestive enzymes, and is easily absorbed for hypoglycemic effect.
1. A method for preparation of orally administrated insulin formulation, comprising:
1) dissolving an amount of insulin in an aqueous buffer, resulting in solution A, of which the pH value is between 3 and 5, and in which the concentration of insulin is 0.1–0.5 mg/mL;
2) adding acidic solution A to a liquid nonionic surfactant or an amphiphilic ester or a mixture thereof with 10<HLB<20, wherein the volume ratio of solution A to that of the surfactant or the amphiphilic ester or their mixture is from 1:5 to 1:50, and then mixing at 5–30° C. with agitation to form homogeneous solution B;
3) adding solution B to an hydrophobic emulsifier with 0<HLB<10, wherein the volume ratio of solution B to that of the hydrophobic emulsifier is from 1:1 to 1:10, and then mixing at 5–30° C. with agitation to form formulation C, which is stored at 4–10° C.;
4) adding an amount of antioxidant, wherein when the antioxidant is hydrophobic, the antioxidant is added to solution B during step 3), and when the antioxidant is hydrophilic, the antioxidant is added to solution A during step 2);
wherein the formulation does not include an oil.
2. The method of claim 1 , wherein the surfactant or amphiphilic ester or their mixture mentioned in step 2) is one or more selected from the group consisting of decaglycerol monooleate, hexaglycerol monolaurate, decaglycerol monooctanoate, polyethylene glycol-8-glycerol octanoate/decanoate, polyglycerol-6-dioleate, sorbitan monooleate polyoxyalkylene (20), phospholipids, glycoester and bile acid or its salt as biological surfactant.
3. The method of claim 1 , wherein the agitation speed in step 2) is in the range of 200–2000 r/min, and the agitation time is in the range of 0.5–5 hours.
4. The method of claim 1 , wherein the hydrophobic emulsifier mentioned in step 3) is one or more selected from the group consisting of triglycerol octanoate/decanoate, glycerol octanoate/decanoate, glycerol oleate, glycerol linoleate, polyglycerol-3-oleate, polyethylene glycol-6-glycerol monooleate, polyethylene glycol-6-glycerol linoleate, sorbitan monooleate, and polyethylene glycol-4-glycerol octanoate/decanoate.
5. The method of claim 1 , wherein the agitation temperature in step 3) is in the range of 5–30° C., the agitation speed is in the range of 200–2000 r/min and the agitation time is in the range of 0.5–5 hours.
6. The method of claim 1 , wherein the amount of the antioxidant added is in the range of 0.01–0.1% by volume of the final solution, and said antioxidant comprises Vitamin E, Vitamin C, cysteine, gallate, or tertiary-butyl hydroquinone.